Pharmaceutical Chemistry Journal

, Volume 31, Issue 9, pp 449–451 | Cite as

Arbidol as the metallothionein inductor in mice

  • G. M. Rott
  • O. A. Smoryzanova
  • V. A. Romantsova
  • E. P. Savina
  • F. A. Trofimov
Molecular-biological Problems of Drug Design and Mechanism of Drug Action


Interferon Supernatant Liquid Zinc Salt Arbidol Interferon Inductor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. D. MashkovskiiDrugs [in Russian], Meditsina, Moscow (1993), Vol. 2, p. 398.Google Scholar
  2. 2.
    I. S. Nikolaeva, A. N. Fomina, E. N. Padeiskaya, et al.,Abstracts of Papers. The 9th All-Union Symp. on the Targeted Search for Drugs [in Russian], Riga (1991), p. 37.Google Scholar
  3. 3.
    US Patent No. 5198552;Byull. Izobret., No. 19-21 (1994).Google Scholar
  4. 4.
    O. M. Oleinikova and E. O. Fedorovskaya,Inductors of Interferon and Other Immunomodulators in Radiology and Oncology [in Russian], Obninsk (1989), pp. 28–35.Google Scholar
  5. 5.
    E. O. Fedorovskaya and S. S. Grigoryan,Inductors of Interferon and Other Immunomodulators in Radiology and Oncology [in Russian], Obninsk (1989), pp. 43–48.Google Scholar
  6. 6.
    E. O. Fedorovskaya, N. G. Tsyshkova, A. P. Poverennyi, et al.,Byull. Eksp. Biol. Med.,118 (7), 80–81 (1994).Google Scholar
  7. 7.
    J. Talmag,Progr. Exp. Tumor Res.,32, 154–173 (1988).Google Scholar
  8. 8.
    N. O. Nartey, D. Banerjee, and M. G. Cherian,Pathology,19, 233–238 (1987).PubMedGoogle Scholar
  9. 9.
    C. D. Klaassen and L. D. Lehman-McKeeman,J. Am. College Toxicol.,8, 1315–1321 (1989).Google Scholar
  10. 10.
    J. H. R. Kagi,Meth. Enzymol.,205, 613–626 (1991).PubMedGoogle Scholar
  11. 11.
    I. Bremner and J. H. Beattie,Ann. Rev. Nutr.,10, 63–83 (1990).CrossRefGoogle Scholar
  12. 12.
    J. U. Bell, M. J. F. Lawman, J. M. Lopez, et al.,Experientia, Suppl.,52, 581–586 (1987).Google Scholar
  13. 13.
    D. L. Eaton and B. F. Toal,Toxicol. Appl. Pharmacol.,66, 134–142 (1982).PubMedCrossRefGoogle Scholar
  14. 14.
    D. L. Eaton and M. G. Cherian,Meth. Enzymol.,205, 83–90 (1991).PubMedCrossRefGoogle Scholar
  15. 15.
    E. B. Tazulakhova,Inductors of Interferon and Other Immunomodulators in Radiology and Oncology [in Russian] Obninsk (1989), pp. 17–24.Google Scholar
  16. 16.
    J. K. Piotrowski, J. A. Szymanska, B. W. Kaszper, et al.,Experientia, Suppl.,52, 639–646 (1987).Google Scholar
  17. 17.
    N. Shiraishi, K. Utsumi, S. Morimoto, et al.,Physiol. Chem. Phys. Med. NMR,14, 533–537 (1982).Google Scholar
  18. 18.
    P. J. Thornalley and M. Vasak,Biochim. Biophys. Acta,827, 36–44 (1985).PubMedGoogle Scholar
  19. 19.
    D. M. Templeton and M. G. Cherian,Meth. Enzymol.,205, 11–24 (1991).PubMedGoogle Scholar
  20. 20.
    I. Bremner,Experientia, Suppl.,52, 81–107 (1987).Google Scholar
  21. 21.
    J. Abel and N. de Ruiter,Toxicol. Lett.,47, 191–196 (1989).PubMedCrossRefGoogle Scholar
  22. 22.
    C. L. Greenstock, C. P. Jinot, R. P. Whitehouse, et al.,Free Radical. Res. Commun.,2, (4–6), 233–239 (1987).Google Scholar
  23. 23.
    M. G. Cherian, P. C. Huang, C. D. Klaassen, et al.,Cancer Res.,53, 922–925 (1993).PubMedGoogle Scholar
  24. 24.
    M. Satoh, Y. Kondo, M. Mita, et al.,Cancer Res.,53, 4767–4768 (1993).PubMedGoogle Scholar
  25. 25.
    M. A. Lynes, L. A. Borghesi, J. H. Young, et al.,Toxicology,85, 161–178 (1993).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • G. M. Rott
    • 1
  • O. A. Smoryzanova
    • 1
  • V. A. Romantsova
    • 1
  • E. P. Savina
    • 1
  • F. A. Trofimov
    • 1
  1. 1.Medical Radiology Research CenterRussian Academy of Medical SciencesObninskRussia

Personalised recommendations